These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 807729)
41. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. Hanly JG; Robichaud J; Fisk JD J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112 [TBL] [Abstract][Full Text] [Related]
42. Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus. Winfield JB; Koffler D; Kunkel HG J Clin Invest; 1975 Sep; 56(3):563-70. PubMed ID: 1080489 [TBL] [Abstract][Full Text] [Related]
43. Circulating DNA:anti-DNA complexes in systemic lupus erythematosus. Detection and characterization by ultracentrifugation. Bruneau C; Benveniste J J Clin Invest; 1979 Jul; 64(1):191-8. PubMed ID: 36410 [TBL] [Abstract][Full Text] [Related]
44. Glomerular deposition of renal tubular epithelial antigen in patients with systemic lupus erythematosus: its possible role in lupus nephritis. Gilboa N; Durante D; McIntosh RM J Rheumatol; 1977; 4(4):358-68. PubMed ID: 604475 [TBL] [Abstract][Full Text] [Related]
45. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Hirohata S; Arinuma Y; Takayama M; Yoshio T Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755 [TBL] [Abstract][Full Text] [Related]
46. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534 [TBL] [Abstract][Full Text] [Related]
47. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Isshi K; Hirohata S Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223 [TBL] [Abstract][Full Text] [Related]
48. Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis? Berden JH; Termaat RM; Brinkman K; Smeenk RJ; Swaak AJ; Faaber P; Assmann K; van de Heuvel LP; Veerkamp JH Nephrologie; 1989; 10(3):127-32. PubMed ID: 2532712 [TBL] [Abstract][Full Text] [Related]
49. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus. Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203 [TBL] [Abstract][Full Text] [Related]
50. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus. Anderson CL; Stillman WS J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484 [TBL] [Abstract][Full Text] [Related]
51. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. Lefkowith JB; Kiehl M; Rubenstein J; DiValerio R; Bernstein K; Kahl L; Rubin RL; Gourley M J Clin Invest; 1996 Sep; 98(6):1373-80. PubMed ID: 8823302 [TBL] [Abstract][Full Text] [Related]
52. Detection of anti-DNA antibody using synthetic antigens. Characterization and clinical significance of binding of poly (deoxyadenylate-deoxythymidylate) by serum. Steinman CR; Deesomchok U; Spiera H J Clin Invest; 1976 May; 57(5):1330-41. PubMed ID: 1262474 [TBL] [Abstract][Full Text] [Related]
53. Antibody avidity for native DNA in lupus nephritis. Koyama A; Narita M; Tojo S Contrib Nephrol; 1975; 4():72-82. PubMed ID: 1235100 [TBL] [Abstract][Full Text] [Related]
54. [Heterogeneity and etiological significance of anti-DNA antibody in systemic lupus erythematosus. Analysis of new DNA-anti DNA immune complexes in the circulatory blood]. Okuda M Nihon Rinsho; 1976; 34(4):738-45. PubMed ID: 133256 [No Abstract] [Full Text] [Related]
56. DNA-anti-DNA complexes account for part of the antihistone activity found in patients with systemic lupus erythematosus. Subiza JL; Caturla A; Pascual-Salcedo D; Chamorro MJ; Gazapo E; Figueredo MA; de la Concha EG Arthritis Rheum; 1989 Apr; 32(4):406-12. PubMed ID: 2706026 [TBL] [Abstract][Full Text] [Related]
57. The prognostic and therapeutic implications of DNA:anti-DNA immune complexes in systemic lupus erythematosus (SLE). Bardana EJ; Harbeck RJ; Hoffman AA; Pirofsky B; Carr RI Am J Med; 1975 Oct; 59(4):515-22. PubMed ID: 1166858 [TBL] [Abstract][Full Text] [Related]
58. Stimulation of polymorphonuclear leukocyte chemotaxis by cold precipitable complexes containing DNA-anti-DNA in active nephritis of systemic lupus erythematosus. Losito A; Cecchini C; Pittavini L; Zampi I Nephron; 1982; 30(4):324-7. PubMed ID: 6981070 [TBL] [Abstract][Full Text] [Related]
59. [Lymphocytotoxic antibodies and systemic lupus. Clinical correlations and prognostic significance]. Bortolotti F; Realdi G; Diodati G; Carniello G; Rigoli AM Boll Ist Sieroter Milan; 1977 Jul; 56(3):244-51. PubMed ID: 302711 [TBL] [Abstract][Full Text] [Related]
60. Determination of anti-DNA antibodies by a modified 125I-labelled DNA-binding test. Elimination of non-specific binding of DNA to non-immunoglobulin basic proteins by using an anionic detergent. Izui S; Lambert PH; Miescher PA Clin Exp Immunol; 1976 Dec; 26(3):425-30. PubMed ID: 795575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]